Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03719001 · ClinicalTrials.gov registry record · Early Phase 1

Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot Study

A Early Phase 1 study, sponsored by University of California, San Francisco.

Completed
Registry status
Early Phase 1
Development phase
40
Enrollment target

NCT03719001: Completed Early Phase 1 study, sponsored by University of California, San Francisco.

NCT03719001 is a Early Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 40 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03719001, a Early Phase 1 study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
Early Phase 1
Development phase
40 participants
Enrollment target

Study Summary

Spontaneous myogenic oscillations will be studied under general anesthesia using finger photoplethysmography. This pilot study will explore potential physiological conditions that will effect the amplitude and/or frequency of myogenic oscillations.

Primary Outcome

change in amplitude and/of frequency of myogenic oscillations

Interventions

  • DRUG Dexmedetomidine
  • DRUG Phenylephrine
  • DRUG Clevidipine
  • OTHER tetanic stimulus
  • OTHER Increased venous pressure

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-10-23
Est. Completion 2022-06-15
Phase Early Phase 1

What the finished NCT03719001 record still lists

NCT03719001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (25% lower).

The record links to 0 conditions, and to 5 interventions - of which Dexmedetomidine is the first listed.

NCT03719001 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03719001 about?

NCT03719001 is a clinical study titled "Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot Study". Spontaneous myogenic oscillations will be studied under general anesthesia using finger photoplethysmography. This pilot study will explore potential physiological conditions that will effect the amplitude and/or frequency of myogenic oscillations.

What is the current status of trial NCT03719001?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2018-10-23. Estimated completion is 2022-06-15.

What interventions are being tested in trial NCT03719001?

The interventions under investigation include: Dexmedetomidine (DRUG), Phenylephrine (DRUG), Clevidipine (DRUG), tetanic stimulus (OTHER), Increased venous pressure (OTHER).

Who is sponsoring clinical trial NCT03719001?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03719001's enrollment target sits among peer trials

40 629th of 2000 higher than 1,312 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03719001, the US trial registry maintained by the National Library of Medicine. NCT03719001 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.